NAD⁺ as a central metabolic hub Regulating the hallmarks of aging: Mechanisms and therapeutic implications
Mechanisms of Ageing and Development · 2026
DOI: 10.1016/j.mad.2026.112174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mechanisms of Ageing and Development, 2026. Verfasst von Zerong Pei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330000, China. Hauptthemen laut MEDLINE: Aging, NAD, Neoplasms, Senescence-Associated Secretory Phenotype. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 205 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Jiangxi Province.
Abstract (Originalsprache)
The increasing global burden of age-related diseases necessitates interventions that target the unified biological processes of aging, as outlined by the expanding framework of fourteen interconnected hallmarks. This review establishes nicotinamide adenine dinucleotide (NAD⁺) as the central metabolic hub that coordinately regulates this entire network. We systematically elucidate the bidirectional mechanistic links between NAD⁺ metabolism and each hallmark, demonstrating how its age-related decline-driven by impaired biosynthesis and heightened consumption-propagates dysfunction across genomic, epigenetic, mitochondrial, proteostatic, and communicative processes. A large body of evidence supports that NAD⁺ can counter functional decline in models of neurodegenerative diseases, cardiometabolic diseases, and musculoskeletal aging However, a critical synthesis of evidence reveals a paradoxical, context-dependent role for NAD⁺, particularly in oncology, where it can sustain the pro-tumorigenic senescence-associated secretory phenotype (SASP) and fuel established cancers. This duality, along with tissue-specific metabolic nuances, underscores the fundamental limitation of indiscriminate "blind supplementation." Consequently, we advocate for a necessary paradigm shift towards "precision NAD⁺ modulation." Building on the integrated mechanistic analysis, we critically examine the therapeutic implications and challenges across major age-related diseases. Looking ahead, we propose that advancing the field requires embracing a "NAD⁺ systems biology" perspective. Design next-generation interventions that precisely balance tissue-specific NAD⁺ synthesis and consumption. This paradigm is essential for translating the promise of NAD⁺ biology into safe and effective strategies for extending human healthspan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330000, China.
- Department of Pharmacy, Tianjin Medical University General Hospital Airport Site, Tianjin, China.
- China Department of Pharmacy, Tianjin First Central Hospital, Tianjin, China.
- Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330000, China; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 10000…
Förderung
- National Key Research and Development Program of China
- Key Research and Development Program of Jiangxi Province
Zitieren
APA
Pei, Z., Liang, F., Wang, X., & Li, H. (2026). NAD⁺ as a central metabolic hub Regulating the hallmarks of aging: Mechanisms and therapeutic implications. Mechanisms of Ageing and Development. https://doi.org/10.1016/j.mad.2026.112174
Vancouver
Pei Z, Liang F, Wang X, Li H. NAD⁺ as a central metabolic hub Regulating the hallmarks of aging: Mechanisms and therapeutic implications. Mechanisms of Ageing and Development. 2026. doi:10.1016/j.mad.2026.112174
BibTeX
@article{Pei2026,
author = {Pei, Zerong and Liang, Fengni and Wang, Xuemei and Li, Hui},
title = {NAD⁺ as a central metabolic hub Regulating the hallmarks of aging: Mechanisms and therapeutic implications},
journal = {Mechanisms of Ageing and Development},
year = {2026},
doi = {10.1016/j.mad.2026.112174}
}
EUVIMED